BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25063260)

  • 1. Variability in compounding of oral liquids for pediatric patients: a patient safety concern.
    Rood JM; Engels MJ; Ciarkowski SL; Wagenknecht LD; Dickinson CJ; Stevenson JG
    J Am Pharm Assoc (2003); 2014; 54(4):383-9. PubMed ID: 25063260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of compounded oral liquids for pediatric patients in Michigan.
    Engels MJ; Ciarkowski SL; Rood J; Wang B; Wagenknecht LD; Dickinson CJ; Stevenson JG
    Am J Health Syst Pharm; 2016 Jul; 73(13):981-90. PubMed ID: 27325879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Compounding in Portuguese Community Pharmacies: CHARACTERIZATION AND FUTURE PERSPECTIVES.
    Palmeira-de-Oliveira R; Macedo M; Machado RM; Pacheco AF; Palmeira-de-Oliveira A; Martinez-de-Oliveira J; Duarte P
    Int J Pharm Compd; 2016; 20(2):114-22. PubMed ID: 27323423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standards for compounding of oral liquids for pediatric patients.
    Cain JM
    J Am Pharm Assoc (2003); 2015; 55(1):4-5. PubMed ID: 25575143
    [No Abstract]   [Full Text] [Related]  

  • 5. Response: standards for compounding of oral liquids for pediatric patients.
    Stevenson JG; Ciarkowski SL; Engels MJ; Rood JM; Wagenknecht LD; Dickinson CJ
    J Am Pharm Assoc (2003); 2015; 55(1):5. PubMed ID: 25575144
    [No Abstract]   [Full Text] [Related]  

  • 6. Devices for securing and administering pediatric compounded oral liquids: survey results from French university hospitals.
    Cavelier M; Hervouët C; Varin R; Gondé H
    Eur J Pediatr; 2024 Jun; 183(6):2805-2810. PubMed ID: 38573361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, nature and determinants of pharmacy compounded medicines in Dutch community pharmacies.
    Buurma H; de Smet PA; van den Hoff OP; Sysling H; Storimans M; Egberts AC
    Pharm World Sci; 2003 Dec; 25(6):280-7. PubMed ID: 14689817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of compounding in independent community pharmacy practice.
    McPherson TB; Fontane PE; Jackson KD; Martin KS; Berry T; Chereson R; Bilger R
    J Am Pharm Assoc (2003); 2006; 46(5):568-73. PubMed ID: 17036642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounding practices and beliefs of Arizona pharmacists.
    Cauthon KA; Bowman BJ; Gurney MK
    Int J Pharm Compd; 2013; 17(2):154-61. PubMed ID: 23696176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions of pharmaceutical care among pharmacists offering compounding services.
    Yancey V; Yakimo R; Perry A; McPherson TB
    J Am Pharm Assoc (2003); 2008; 48(4):508-14. PubMed ID: 18653427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized compounding in community pharmacies: organizational perspective.
    Giam JA; McLachlan AJ; Krass I
    J Am Pharm Assoc (2003); 2010; 50(3):354-61. PubMed ID: 20452908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
    Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
    Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounding practices in a Portuguese community pharmacy.
    Reis M; Carvalho M; Rodrigues A
    Int J Pharm Compd; 2014; 18(5):392-5. PubMed ID: 25577888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Current Landscape of Veterinary Compounding in the Pharmacy Setting.
    Gochenauer AE; Holmes ER; Barber KE; Forsythe LR
    Int J Pharm Compd; 2019; 23(5):422-427. PubMed ID: 31513542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Services provided by community pharmacies in Wayne County, Michigan: a comparison by ZIP code characteristics.
    Erickson SR; Workman P
    J Am Pharm Assoc (2003); 2014; 54(6):618-24. PubMed ID: 25379982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practices of pharmacies that compound extemporaneous formulations.
    Treadway AK; Craddock D; Leff R
    Am J Health Syst Pharm; 2007 Jul; 64(13):1403-9. PubMed ID: 17592006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2008; 12(1):74-82. PubMed ID: 23969574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and facilitators to recovering from e-prescribing errors in community pharmacies.
    Odukoya OK; Stone JA; Chui MA
    J Am Pharm Assoc (2003); 2015; 55(1):52-8. PubMed ID: 25539495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updating formulations for compounded oral liquid medications in a university health system.
    Stumpf JL; Leja N; Ciarkowski SL; Salah S; Schaeffler KL
    Am J Health Syst Pharm; 2018 Sep; 75(18):1394-1398. PubMed ID: 30006436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.